Traynor Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,909	Closed	-$23.9K	–	236
2023 Q3	$23.9K	Buy	21,909 +1,103	+5%	+$1.2K	﹤0.01%	194
2023 Q2	$47.6K	Buy	20,806 +1,742	+9%	+$3.99K	0.01%	190
2023 Q1	$46.3K	Buy	+19,064	New	+$46.3K	0.01%	183